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The cytokine erythropoietin (Epo) mediates various cell homeostatic responses to
environmental challenges and pathological insults. While stimulation of vertebrate
erythrocyte production is mediated by homodimeric “classical” Epo receptors, alternative
receptors are involved in neuroprotection. However, their identity remains enigmatic due
to complex cytokine ligand and receptor interactions and conflicting experimental results.
Besides the classical Epo receptor, the family of type I cytokine receptors also includes the
poorly characterized orphan cytokine receptor-like factor 3 (CRLF3) present in vertebrates
including human and various insect species. By making use of the more simple genetic
makeup of insect model systems, we studied whether CRLF3 is a neuroprotective Epo
receptor in animals. We identified a single ortholog of CRLF3 in the beetle Tribolium
castaneum, and established protocols for primary neuronal cell cultures from Tribolium
brains and efficient in vitro RNA interference. Recombinant human Epo as well as the
non-erythropoietic Epo splice variant EV-3 increased the survival of serum-deprived brain
neurons, confirming the previously described neuroprotective effect of Epo in insects.
Moreover, Epo completely prevented hypoxia-induced apoptotic cell death of primary
neuronal cultures. Knockdown of CRLF3 expression by RNA interference with two
different double stranded RNA (dsRNA) fragments abolished the neuroprotective effect of
Epo, indicating that CRLF3 is a crucial component of the insect Epo-responsive receptor.
This suggests that a common urbilaterian ancestor of the orphan human and insect
cytokine receptor CRLF3 served as a neuroprotective receptor for an Epo-like cytokine.
Our work also suggests that vertebrate CRLF3, like its insect ortholog, might represent a
tissue protection-mediating receptor.
Keywords: erythropoietin, non-erythropoietic splice variant, neuroprotection, cytokine receptor, primary neuronal
cell culture, RNA interference, Tribolium castaneum
INTRODUCTION
Erythropoietin (Epo) is a positive regulator of vertebrate erythropoiesis. Circulating hormonal Epo,
predominantly released by the kidney in adult mammals, stimulates homodimeric Epo receptors
(‘‘classical EpoR’’) on Epo-responsive erythroid progenitor cells in the bone marrow that initiate
anti-apoptotic mechanisms leading to increased numbers of red blood cells (Jelkmann, 1992).
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Epo is also synthesized and released as a para- or autocrine
signal in various tissues that initiates adaptive cellular responses
to injury and physiological challenges in order to support
cell survival, maintenance of functions and regeneration
(Noguchi et al., 2008; Sargin et al., 2010; Chateauvieux
et al., 2011). In the nervous system, Epo is produced by
glia, neurons and endothelial cells. Epo plays important
roles during mammalian brain development (Alnaeeli et al.,
2012), acts as a protectant that secures neuronal survival
and functionality under ischemic, cytotoxic and otherwise
deleterious conditions (Brines and Cerami, 2005; Arcasoy, 2008;
Sargin et al., 2010), supports regeneration (Kretz et al., 2005;
King et al., 2007) and enhances cognitive performance in
healthy and diseased brains (Sargin et al., 2011; Kästner et al.,
2012). Although expression of classical EpoR in the brain
has been demonstrated by numerous studies, Epo receptors
mediating neuroprotection seem to be different from the classical
homodimeric EpoR involved in erythropoiesis (Leist et al., 2004;
Brines and Cerami, 2005). Several Epo-like molecules have been
demonstrated to lack erythropoietic functions while retaining full
neuroprotective activity compared to normal Epo. Such tissue-
specific agonists include the derivatives carbamylated Epo and
asialoerythropoietin (Erbayraktar et al., 2003; Leist et al., 2004),
mutant Epo with serine to leucine mutation at position 104 (Gan
et al., 2012) and the human Epo splice variant EV-3 with deleted
third exon (Bonnas, 2012). The nature of the neuroprotective Epo
receptor is currently debated. As non-erythropoietic candidate
receptors, common β chain receptor/classical EpoR heteromers
expressed in the nervous system (Brines and Cerami, 2005;
Collino et al., 2015) and bone tissue (Duedal Rölfing et al.,
2014) and leukemia inhibitory factor LIFR/DC130 expressed
in neuronal and other cell lines (Bonnas, 2012) are discussed.
However, even within a particular tissue such as the nervous
system, the expression of Epo receptors may depend on cell type,
developmental stage, physiological condition and actual as well as
previous exposure to challenging stimuli (Sinor and Greenberg,
2000; Brines and Cerami, 2005; Shein et al., 2005; Um et al.,
2007; Sanchez et al., 2009). Cells may flexibly respond to different
physiological challenges by expressing different Epo receptors
that activate particular adaptive cellular responses.
Genes for Epo and classical EpoR are present in all major
vertebrate groups including mammals, amphibia and fish
(Ostrowski et al., 2011), suggesting that Epo/EpoR signaling
already evolved when the vertebrate lineage emerged. Based
on protein sequence similarity, which is already quite low
between mammals and fish, no orthologs of Epo and EpoR
have so far been identified in invertebrate species. Nevertheless,
Epo-mediated neuroprotection and neuroregeneration have
been described in grasshoppers and locusts (Ostrowski et al.,
2011; Miljus et al., 2014). In these studies recombinant human
Epo rescued primary cultured brain neurons from hypoxia-
induced apoptotic cell death by activating Janus kinase/signal
transducers and activators of transcription (JAK/STAT)
transduction pathways (Miljus et al., 2014). In addition, locust
brain neurons were also protected by the non-erythropoietic
human splice variant EV-3 (Miljus et al., 2017; characterization
of EV-3 by Bonnas et al., 2017), suggesting that insect and
mammalian neuroprotective Epo receptors share common
structures that allow activation by both Epo and EV-3. These
findings support the hypothesis of a pre-vertebrate evolution
of Epo-like signaling in neuroprotection (Brines and Cerami,
2005).
Epo belongs to the group of type I helical cytokines that,
in spite of low primary sequence similarity, share spatial
similarity emerging from a characteristic four-helix bundle
structure (Boulay et al., 2003). Their corresponding receptors
(type I cytokine receptors) contain a conserved 200 amino
acid ‘‘cytokine receptor homology domain’’ required for ligand
binding and some conserved intracellular motifs that allow the
activation of JAK/STAT transduction pathways (Boulay et al.,
2003; Liongue and Ward, 2007). Cytokine type I receptors
typically associate to homo- or heteromeric receptor complexes
that may bind several cytokine ligands.
Classical EpoR belongs to group 1 of cytokine type I receptors,
which also includes thrombopoietin receptor, prolactin receptor,
growth hormone receptor and the orphan cytokine receptor-like
factor 3 (CRLF3) of unknown function. CRLF3 (synonyms:
CYTOR4, CREME9, p48.2, p48.6 (sequences may deviate by few
amino acids at the 5′ end) has been shown to activate STAT3,
cause cell cycle arrest in a human embryonic kidney cell line
(Yang et al., 2009) and may regulate neuronal morphology and
synaptic vesicle formation (Hashimoto et al., 2012). Crlf3 is
located on human chromosome 17 and is expressed in most
normal human tissues including the nervous system. Variations
of crlf3 sequences have been associated with amyotrophic lateral
sclerosis (ALS; Cirulli et al., 2015) and increased CRLF3 content
has been detected in various tumor cell lines and freshly isolated
tumors (Dang et al., 2006; Yang et al., 2009). Crlf3 is well
conserved which allowed the identification of orthologs in
various mammals, fish, primitive chordates and insects, such
as the beetle Tribolium castaneum and the cricket Gryllus
bimaculatus but not in the fly Drosophila melanogaster (Wyder
et al., 2007). Interestingly, we were able to show a neuroprotective
effect of Epo on T. castaneum (this study) and G. bimaculatus
neural cells but failed to do so in D. melanogaster (unpublished
results) which led us to hypothesize that CRLF3 might be
mediating this effect.
The red flour beetle T. castaneum has a fully sequenced
genome and is amenable to double stranded RNA (dsRNA)-
mediated systemic RNAi (Bucher et al., 2002). In order to explore
the possibility that beetle CRLF3 (Tc-CRLF3) plays a role in
Epo-mediated neuroprotection, we established primary neuronal
cell cultures from T. castaneum brains and effective soaking
RNA interference by dsRNA added to the culture medium. We
demonstrate that knockdown of Tc-CRLF3 expression abolishes




A 427 bp long fragment of the red fluorescent protein (dsRed) of
the mushroom anemona Discosoma spec. was cloned into pCRII
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vector by the Bucher Lab. Additionally, 300 bp of Rpt3 were
cloned into pJet 1.2 (Thermo Fisher Scientific, Waltham, MA,
USA; Ulrich et al., 2015). For RNAi experiments targeting
Tc-CRLF3, primer pairs for two different fragments targeting
au3.g2971.t1 (Tc000209) were designed (Table 1). The fragment
1 covers 638 bp whereas the fragment 2 is smaller and consists
of 527 bp (sequences shown in Supplementary Figure S1).
The fragments were cloned into the pCRII vector using the
TA Cloningr Kit (Invitrogen, Life Technologies, Darmstadt,
Germany). Subsequently, the plasmids were transformed into
DH5α cells and finally purified with the NucleoSpinr Plasmid
Kit (Macherey-Nagel, Düren, Germany).
Preparation of dsRNA
Template DNA was prepared by PCR using M13F and M13R
primers with a T7 RNA polymerase promoter sequence attached
to the latter (Table 1). In vitro transcription of dsRNA
was performed with the MEGAscriptr T7 Transcription Kit
following the user manual (Life Technologies, Darmstadt,
Germany). The resulting RNA pellet was resuspended in
injection buffer (1.4 mM NaCl, 0.07 mM Na2HPO4, 0.03 mM
KH2PO4, 4 mM KCl). In order to anneal both strands
of the RNA, the mix was incubated at 94◦C for 5 min
and cooled down slowly in a heatblock. Before use in
cell culture experiments it was sterile filtered (Millexr-
HV, 0.45 µm, hydrophilic durapore, Millipore, Darmstadt,
Germany).
Sequence Comparison
Information about Tribolium gene sequence and structure
was gained from http://bioinf.uni-greifswald.de/gb2/gbrowse/
tribolium4/ working with the augustus3 prediction. Sequences
were identified with Basic Local Alignment Search Tool (BLAST;
Altschul et al., 1990) using the matrix BLOSUM62 with standard
settings and the mode tblastn. Sequence information of other
species was retrieved with BLAST at NCBI data bases (Altschul
et al., 1990).
Geneiousr (Biomatter Ltd., Auckland, New Zealand) was
utilized for alignments using the algorithm ClustalW with
standard settings. To identify orthologs of Tribolium castaneum
CRLF3, a phylogenetic tree was built with the bootstrap
resembling method and standard settings as follows: The initial
protein sequence alignment was created with the first three hits
of Tribolium castaneum and Drosophila melanogaster and the
first four hits of Mus musculus. Domains with high quality of
alignments were extracted and concatenated for tree building.
Phylogenetic analysis of the CRLF3 protein was also
performed with Geneiousr. Orthologous amino acid sequences
were aligned with ClustalW algorithm with standard settings.
The tree was calculated using the Geneiousr tree builder with
Neighbor-Joining method and bootstrap resampling with default
settings. The analysis includes CRLF3 orthologs of the human
CRLF3 protein identified by NCBI BLAST. They belong to
Homo sapiens (GenBank accession number NP_057070.3),
Mus musculus (NP_061246.1), Danio rerio (NP_001017817.2),
Xenopus laevis (NP_001080600.1), Branchiostoma floridae
(XP_002607148.1), Ciona intestinalis (NP_001107600.1) and
Tribolium castaneum (XP_008190449.1).
Animals
Studies were performed with red flour beetles Tribolium
castaneum (wild-type strain San Bernadino). The beetles were
bred in plastic boxes filled with a mixture of full grain flour
(Wheat flour type 405; Rosenmühle GmbH, Landshut, Germany)
and yeast at 27◦C and 40% air humidity. The study was
conducted exclusively with insects. Studies on insects do not
require special permit. All experiments comply with the German
laws for animal welfare (‘‘Deutsches Tierschutzgesetz’’).
Primary Cultures of T. Castaneum
Brain Cells
Primary cultures were established from brains of late pupae.
Brains were extracted from head capsules and collected in
2 ml sterile growth medium (Leibovitz’s L-15 (Gibco, Karlsruhe,
Germany) supplemented with 0.5% gentamicin (BioReagent,
Munich, Germany)). All brains used in one experiment
(20 brains per treatment group) were pooled at this stage. After
three exchanges of the medium, the brains were exposed to
a mixture of collagenase and dispase (each 2 mg/ml; Sigma-
Aldrich, Munich, Germany) for 45 min at 27◦C to digest
extracellular matrix proteins. Enzymatic activity was terminated
by several washes in Hanks’ Balanced Salt Solution (Gibco,
Karlsruhe, Germany). Brain tissue was passed several times
through the tip of a 100 µl pipette to dissociate the brain
cells. The suspension was centrifuged with 3000 g for 1 min
and the pellet containing the cells was resuspended in L-15
medium with 0.5% gentamicin (100 µl per treatment group).
The dissociated cells were equally allocated onto concanavalin
A-coated (Sigma-Aldrich, Munich, Germany) round cover slips
(Type DKR0; Hartenstein; Würzburg, Germany; Ø 10 mm;
100 µl per cover slip) that were placed in sterile plastic culture
dishes (Corning Inc., New York, NY, USA; Ø 35 mm). After
2 h the culture dishes were filled to a volume of 2 ml with L-
15/0.5% gentamicin ± supplements as specified below. Cultures
were maintained in an incubator (27◦C; humidified atmosphere)
and medium was replaced every 2 days.
Immunocytochemistry
Primary cell cultures were fixed with 4% paraformaldehyde
dissolved in 0.1 M phosphate buffer for 15 min at room
temperature. Cells were washed with phosphate buffered
saline (PBS) and PBS with 0.1% Triton-X-100 (Sigma-
Aldrich, Munich, Germany; PBST), each three times for
5 min. Cells were incubated for 1 h with blocking solution
containing 2% normal goat serum (GE Healthcare, Munich,
Germany) and 0.25% bovine serum albumin (MP Biochemicals,
Heidelberg, Germany) dissolved in PBST. Primary antisera were
incubated over night at 4◦C. To label neuronal membranes
anti-horseradish peroxidase (anti-HRP from rabbit, Sigma
Aldrich) was applied in 1:500 dilution in blocking buffer. To
label the activated form of caspase-3, anti-cleaved caspase-3
serum from rabbit (Calbiochem, Merck, UK) was applied in
1:300 dilution in blocking buffer. After several washes in PBS,
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cells were incubated with 1:200 diluted Alexa 488-coupled
anti-rabbit secondary antibody (developed in goat, Molecular
Probes, Thermo Fisher Scientific, Waltham, MA, USA) for
2 h at room temperature. In some experiments, DAPI
(Sigma-Aldrich, Munich, Germany; 1:1000) was applied
with the secondary antibody. After washing away excess
antibody, cover slips with labeled cells were mounted with
1,4-diazobicyclo[2.2.2]octane (DABCO, Roth, Karlsruhe,
Germany) on microscopic slides. Edges of cover slips were sealed
with transparent nail polish and stainings were analyzed by
fluorescence microscopy.
Protective Effect of rhEpo and EV-3 on
T. Castaneum Brain Cells In Vitro
Four-day-old primary cultures were maintained in L-15 medium
supplemented with 0.5% gentamicin. Particular cultures were
incubated with different concentrations (0.32 ng/ml, 0.8 ng/ml,
3.2 ng/ml, 8 ng/ml, 32 ng/ml) of recombinant human Epo
(rhEpo, NeoRecormon, Roche, Welwyn Garden City, UK) or
(0.42 ng/ml, 0.84 ng/ml) of the human non-erythropoietic Epo
splice variant EV-3 (IBA GmbH, Göttingen, Germany) for
another 3 days. Cell cultures were fixed in paraformaldehyde
(4%, 30 min), labeled with DAPI (Sigma-Aldrich, Munich,
Germany; 1:1000) and mounted with DABCO (Roth, Karlsruhe,
Germany) on microscopic slides to quantify cellular survival (see
below).
Soaking RNA Interference
Primary cultures of T. castaneum brains were maintained in L-15
medium supplemented with 0.5% gentamicin for 4 days. Each
experiment, using the cultured cells from the same population
of 80 brains, contained four different treatment groups, one
control, incubated without any supplement throughout the
entire period and three cultures that were supplemented
with 10 ng/µl dsRNA to suppress the expression of dsRed
(a protein not naturally expressed by the cells), Tc-CRLF3
(T. castaneum ortholog of CRLF3) and (Regulatory particle
triple-A ATPase 3 (Rpt3), a protein of the proteasome that
is essential for cellular survival), respectively (for dsRNA
sequences see Supplementary Figure S1). After 4 days in vitro,
cell cultures were fixed and labeled with DAPI as described
above.
Survival in Hypoxia
Primary cultures of T. castaneum brains were maintained
in L-15 medium supplemented with 0.5% gentamicin for
5 days. Each experiment, using the cultured cells from
the same population of 100 brains, contained five different
treatment groups: (1) untreated control maintained in normoxic
condition; (2) untreated control exposed to hypoxia; (3) rhEpo-
treated culture exposed to hypoxia; (4) rhEpo-treated culture
exposed to hypoxia after RNAi-mediated suppression of Tc-
CRLF3 expression; and (5) hypoxia-exposed culture after RNAi
mediated suppression of Tc-CRLF3 expression. dsRNA (final
concentration 10 ng/µl) was present in the respective cultures
throughout the entire experimental period. To minimize the risk
for off-target effects, two dsRNA constructs (see Supplementary
Figure S1) that target non-overlapping sequences were used
to interfere with Tc-CRLF3 expression. rhEpo (0.8 ng/ml)
was added to the respective cultures 12 h before the hypoxic
period. Hypoxia was generated by floating an airproof chamber
(22.5 × 4.5 × 4 cm, workshop of our institute) with
nitrogen (N2). Hypoxia (O2 level ≤ 2%) was monitored
with an oxygen analyzer (Greisinger GOX 100, Conrad
Electronics, Hirschau, Germany) and maintained for 36 h.
Afterwards, cultures were reoxygenated, maintained for 12 h
in normoxia, and subsequently fixed and labeled as described
above.
Data Analysis
Assessment of cellular survival was based on chromatin
structure revealed by fluorescent labeling with DAPI (Gocht
et al., 2009). Using a fluorescence microscope (Zeiss Axioskop,
Oberkochen, Germany) with 63× oil objective, equipped with
a CCD camera (Spot RT3, Visitron, Puchheim, Germany),
two continuous rows of non-overlapping photographs were
taken (typically ∼120 per culture), that extended over the
entire cover slip to the right and the left of the center.
Numbers of nuclei from alive and dead cells (at the time of
fixation) were manually counted with the freeware software
Fiji and its cell counter plugin (ImageJ by NIH). Relative
numbers of alive cells were calculated for each culture.
Within each experiment (that included cultured neurons
from the brains of the same individuals) the values were
normalized to survival in the untreated control culture (=ˆ100%).
Differences in data population distributions were probed with
the non-parametric Kruskal-Wallis test, and the Mann-Whitney
U test for unmatched samples was used to determine the
differences between two groups (statistics performed with
OriginPro 8.5, OriginLab Corporation). To adjust the false
discovery rate, P values were corrected with the Benjamini-




The T. castaneum gene prediction au3.g2971.t1 (Tc000209,
Tc-crlf3) is an ortholog of the human crlf3. It is located
on chromosome linkage group 2 (ChLG2) at position
14179075–14181074. The size of the mRNA is 1803 bp and
the coding sequence, distributed over five exons, comprises
1272 bp. Conserved domains of the 424 amino acid containing
Tc-CRLF3 protein include a fibronectin type III domain,
a cytokine receptor motif and interdomain contacts
(Supplementary Figure S2).
A phylogenetic tree revealed clear orthology of human,
mouse and Tribolium CRLF3 proteins (Figure 1A). Importantly,
no further paralogs were detected in Tribolium which could
act redundantly and possibly rescue RNAi-induced phenotypes
(Figure 1A).
CRLF3 orthologs are present in mammals, amphibia, fish,
cephalochordates, tunicates and insects. Among insects, crlf3
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FIGURE 1 | Unrooted phylogenetic trees showing the relationship of cytokine receptor-like factor 3 (CRLF3) proteins. (A) Phylogenetic tree originating from Basic
Local Alignment Search Tool (BLAST) with the human CRLF3 protein sequence (Hs_CRLF3). Protein sequences from Tribolium castaneum (Tc), Drosophila
melanogaster (Dm) and Mus musculus (Mm) were considered for the alignment. Tribolium Tc-CRLF3 (red box) is an ortholog of the human CRLF3 since it belongs to
the CRLF3 group. Paralogs are not present in Tribolium. (B) CRLF3 orthologs of Homo sapiens (Hs), Mus musculus (Mm), Danio rerio (Dr), Xenopus laevis (Xl),
Branchiostoma floridae (Bf), Ciona intestinalis (Ci) and Tribolium castaneum (Tc) were compared with respect to phylogenetic relationship. Orthologs of mammalian as
well as of vertebrate CRLF3 separate in well supported branches. Table 2 summarizes the identity of the respective proteins.
TABLE 1 | Sequences of primers.
Primer Sequence
crlf3 fragment 1 forward 5′ GGGTGATAGGAACGAAGTGGTGGA 3′
crlf3 fragment 1 reverse 5′ GACGTCATATCTGAGAAACACTTAG 3′
crlf3 fragment 2 forward 5′ CGATTGTTATGTGGGCGCAGAGAC 3′
crlf3 fragment 2 reverse 5′ GAGTCAGTATTGATACGTGTAACA 3′
M13F (−20) 5′ GTAAAACGACGGCCAGT 3′
T7-M13R (−17) 5′ TAATACGACTCATAGGCAGGAAACAGCTATGAC 3′
T7-pJet1.2 forward 5′ TAATACGACTCACTATAGGCGACTCACTATAGGGAGAGC 3′
T7-pJet1.2 reverse 5′ TAATACGACTCACTATAGGAAGAACATCGATTTTCCATGGCAG 3′
genes were identified in the beetle T. castaneum and the cricket
Gryllus bimaculatus (1Gene: GB-isotig00932) but not in fruit
flies, mosquitoes and honey bees (Wyder et al., 2007). On
the protein level, Tc-CRLF3 shares 28% sequence similarity
with its human and mouse orthologs, 29% with X. laevis
and 26% with zebrafish (Table 2). Respective proteins of the
lancelet B. floridae and the tunicate C. intestinales share 27%
and 24% similarity with Tc-CRLF3. Analysis of phylogenetic
relationships among CRLF3 proteins of these species reflects
the evolutionary lineages (Figure 1B). Orthologs of mammalian
(mouse and human) as well as of vertebrate (mammals together
with frog and fish) CRLF3 form branches that are well-separated
from the other species. The non-vertebrate species differ
significantly from each other, with CRLF3 of Tribolium showing
1http://asgard.rc.fas.harvard.edu/blast.html
stronger similarity with Ciona than with the other chordate
Branchiostoma.
Primary Cell Culture from Brains
of T. Castaneum
Freshly dissociated primary cell cultures contained round shaped
cells that were typically devoid of processes (Figure 2A). Neurons
and eventually also glia lose their axons, dendrites and other
processes during the dissociation procedure. It is assumed that a
large portion of cells is irreversibly damaged during this process
preventing their attachment to the concanavalin A-coated cover
slips and subsequent survival in vitro. After 1 day, cultures
in full medium with 5% FBS contained approximately 65%
alive cells while survival in serum-free cultures was reduced
to approximately 40% of adherent cells. Primary cultured
neurons regenerated neurites that became visible after 3 days
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TABLE 2 | Across species similarities of amino acid sequences of cytokine receptor-like factor 3 (CRLF3) orthologs.
H. s. M. m. CRLF3 D. r. X. l. B. f. hyp. protein C. i. class I T. c.
CRLF3 isoform 1 CRLF3 CRLF3 BRAFLDRAFT_68058 CRLF3 CRLF3
H. sapiens 442 aa 93% 66% 70% 34% 28% 28%
M. musculus 93% 442 aa 65% 70% 33% 28% 28%
D. rerio 66% 65% 444 aa 59% 36% 28% 26%
X. laevis 70% 70% 59% 436 aa 35% 28% 29%
B. floridae 34% 33% 36% 35% 441 aa 30% 28%
C. intestinalis 28% 28% 28% 28% 30% 463 aa 24%
T. castaneum 28% 28% 26% 29% 27% 24% 424 aa
Shaded cells contain total numbers of amino acids of respective proteins. GenBank accession numbers of sequences: H. sapiens (human) NP_057070.3; M. musculus
(mouse) NP_061246.1; D. rerio (zebrafish) NP_001017817.2; X. laevis (frog) NP_001080600.1; B. floridae (lancelet) X P_002607148.1; C. intestinalis (tunicate)
NP_001107600.1; T. castaneum (beetle) X P_008190449.1.
FIGURE 2 | Primary cell culture from T. castaneum brains. (A) Cultured brain
ells 3 h after dissociation. (B) Cultured brain neurons labeled with
anti-horseradish peroxidase (anti-HRP) (green) and DAPI (white) after 6 days
in vitro. Inset shows regenerated neurites with optimized brightness and
contrast. (C) Cultured brain cells after 1 day in vitro. Left and middle: DAPI
labeling. Right and middle: anti-HRP immunofluorescence. ∗ Intact neurons,
#dying neuron, onucleus of dead or dying cell, + intact glial cell. (D) DAPI labels
heterochromatin DNA structures in nuclei of intact cells (∗) and condensed
nuclei with largely fragmented DNA of dead or dying cells (o). (E) Anti-cleaved
caspase-3 immunofluorescence (green) in the cytoplasm of apoptotic cells.
Dead cells (condensed DAPI-labeled nuclei) lose their cleaved caspase-3
associated fluorescence after disintegration of cellular membranes. Activated
caspase-3 is absent from the cytoplasm of intact cells with discontinuously
DAPI-labeled nuclei.
in vitro and subsequently increased in length and complexity
of arborizations (Figure 2B). Whether anatomical contacts of
processes developed into functional synapses was not studied.
Neurons and glia were distinguished by the presence or absence
of anti-HRP immunoreactivity (Figure 2C). Anti-HRP has been
demonstrated to label neuron-specific membrane proteins in
various arthropods and anti-HRP immunocytochemistry is a
simple, reliable and widely used method to identify insect
neurons (Jan and Jan, 1982; Sun and Salvaterra, 1995; Gocht
et al., 2009). However, since cytoplasmic membranes disintegrate
in dying or dead cells, anti-HRP immunocytochemistry cannot
distinguish between dead neurons and glia (e.g., the nucleus
marked with ‘‘o’’ in the center of Figure 2C). As it was
previously described for primary cultures from locust brains
(Vanhems and Delbos, 1987; Gocht et al., 2009), fresh cultures
from T. castaneum brains contained low numbers of glia and
no glial cells were detected after 4 days in vitro. Viability
of primary cultured cells was reflected in the pattern of the
DNA-binding fluorescent dyeDAPI (Figure 2D). Nuclei of intact
cells (both neurons and glia, Figure 2C) display a patchy staining
pattern that corresponds to intact chromatin structures. DNA
fragmentation, that goes along with apoptotic cell death, leads
to condensed and uniformly DAPI-labeled nuclei. Apoptotic
cell death in cultured insect neurons can be induced by serum-
deprivation, hypoxia and other physiological stressors (Jenkins
et al., 2013; Miljus et al., 2014). Caspase activation involved in
apoptosis can be detected in T. castaneum brain cell cultures by
anti-cleaved caspase-3 immunocytochemistry (Figure 2E).
Epo and EV-3 Increase the Survival
of T. Castaneum Brain Neurons
Cellular survival in untreated control cultures and cultures
exposed to different concentrations of rhEpo or EV-3 was
assessed after 7 days in vitro. Pharmacological treatment
started after 4 days in vitro, when cultures were devoid of
glia and exclusively contained neurons that could be labeled
with anti-HRP immunocytochemistry (Figures 2B,C). rhEpo
concentrations of 0.8 and 3.2 ng/ml significantly increased
neuronal survival in cultures deriving from identical pools of
brain cells (both with p < 0.001 compared to controls) while
32 ng/ml rhEpo reduced viability (p< 0.05 compared to control;
Figure 3A). The human non-erythropoietic Epo splice variant
EV-3 also significantly (p < 0.05 for 0.42 ng/ml EV-3 and
p< 0.01 for 0.84 ng/ml EV-3 compared to control) increased the
survival of T. castaneum brain neurons in vitro (Figure 3B).
RNAi in Cultured Brain Neurons
RNAi by application of dsRNA to the extracellular space is
frequently described as soaking RNAi. In order to test, whether
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FIGURE 3 | Effect of recombinant human Epo (rhEpo) and EV-3 on cellular survival of T. castaneum primary brain cell cultures after 7 days in vitro. (A) In comparison
to untreated control cultures 0.8 and 3.2 ng/ml rhEpo significantly increase cellular survival (p = 0.00088 for both). In contrast, 32 ng/ml rhEpo decreases cellular
survival compared with untreated control cultures (p = 0.01202) and cultures exposed to lower concentrations of rhEpo (0.32 ng/ml: p = 0.02603, 0.8 ng/ml:
p = 0.00233, 3.2 ng/ml: p = 0.00233). N = 8, 64,518 cells evaluated. (B) EV-3 increases cellular survival (0.42 ng/ml: p = 0.04762; 0.84 ng/ml: p = 0.00794). N = 7,
42,355 cells evaluated Statistics: non-parametric Kruskal-Wallis test and Mann-Whitney U test with Benjamini-Hochberg correction. ∗∗∗p < 0.001, ∗∗p < 0.01,
∗p < 0.05. Significance is shown with respect to the treatment group marked by the arrowhead. Schematics in the upper part describe experimental procedure with
initial 4 days of culturing in full medium and 3 days of rhEpo or EV-3 exposure.
the mechanisms underlying dsRNA uptake and RNAi are
retained in cultured brain cells, dsRNA fragments targeting
the expression of three different proteins (one that does not
exist in T. castaneum, one that is essential for cellular survival
and two fragments targeting Tc-CRLF3) were applied to the
culture medium for 4 days. DsRNA targeting the expression
of Rpt3 dramatically reduced cellular survival in comparison
to untreated control cultures that derived from the same pools
of brains (Figures 4A,B), indicating effective dsRNA uptake
and knockdown of expression of this essential proteasomal
protein. In contrast, cell survival was not affected by dsRNA
targeting dsRed, a protein that is not naturally expressed in
insect cells (Figure 4A). Thus, uptake of dsRNA per se did
not compromise the viability of cultured brain cells. Similarly,
dsRNA targeting the expression of Tc-CRLF3 (fragment 2:
Figure 4A and fragment 1: Figure 4B) had no impact on
cellular survival, suggesting that the reduction of Tc-CRLF3
expression is not critical for cell survival under normal culture
conditions.
Knockdown of Tc-CRLF3 Expression
Abolishes the Neuroprotective Effect
of rhEpo
In order to evaluate the role of Tc-CRLF3 in Epo-mediated
neuroprotection, we performed two independent series of
experiments (experimental procedure shown in Figure 5A) in
which Tc-CRLF3 expression was suppressed by interference
with two different dsRNAs, targeting different, non-overlapping
fragments of the transcript (fragment 1 and fragment 2).
Exposure to hypoxia for 36 h significantly reduced cellular
survival in comparison to cultures that were maintained
under normoxic conditions (Figure 5B, p < 0.001; Figure 5C,
p < 0.001). Incubation with 0.8 ng/ml rhEpo completely
prevented hypoxia-induced cell death (Figure 5B, p < 0.001;
Figure 5C, p < 0.001). Since all cultures were maintained in
serum-free medium, which acts as a mild stressor for cellular
survival, survival in rhEpo-treated/hypoxia-exposed cultures
was even higher than in normoxic controls. RNAi-mediated
knockdown of Tc-CRLF3 expression completely abolished the
neuroprotective effect of rhEpo in hypoxia-exposed neuronal
cultures. RNAi targeting both fragment 1 (Figure 5B) and
fragment 2 (Figure 5C) significantly decreased cellular survival
compared to rhEpo-treated/hypoxia-exposed cultures (both
with p < 0.001) and normoxic controls (both with p < 0.001).
Tc-CRLF3-directed RNAi had no additional deleterious effect
on hypoxia-exposed neuronal cultures (Figures 5B,C) which is
in line with our control experiment where Tc-crlf3 RNAi did
not change survival in normal cell cultures (Figure 4). Thus,
knockdown of Tc-CRLF3 expression eliminates Epo-mediated
neuroprotection of T. castaneum brain neurons, without
compromising cellular survival under neither normoxic
(Figures 4A,B) nor hypoxic (Figures 5B,C) conditions. This
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FIGURE 4 | Soaking RNAi in primary cultures of T. castaneum brain cells. (A) Cellular survival after 4 days in culture medium without serum (control) and
supplemented with 10 ng/µl double stranded RNA (dsRNA) to suppress expression of the anemonal protein dsRed that is not naturally expressed in insects,
Tc-CRLF3 (fragment 2) and the proteasomal protein Rpt3. N = 6, 60,498 cells evaluated. (B) Cellular survival after 4 days in culture medium without serum (control)
and supplemented with 10 ng/µl dsRNA to suppress expression of Tc-CRLF3 (fragment 1) and the proteasomal protein Rpt3. N = 6, 66,505 cells evaluated.
Proportions of surviving cells were normalized to control cultures from the same pool of brain cells without dsRNA supplement (=100%). Statistics: non-parametric
Kruskal-Wallis test and Mann-Whitney U test with Benjamini-Hochberg correction.
confirms the assumption that Tc-CRLF3 is the receptor
mediating Epo neuroprotective effects in T. castaneum.
DISCUSSION
Cytokines and their receptors coordinate many physiological
processes that adapt organisms to changing environments and
maintain cellular functionality under unfavorable conditions.
Cytokines include a heterogeneous collection of glycoproteins
that typically activate multiple types of receptors. Cytokine
receptors, typically hetero- or homo-multimeric complexes,
can be activated by multiple different cytokine ligands
(review: Dinarello, 2007). Overlapping and complementary
functions of cytokines together with low primary sequence
similarities of cytokines and many types of cytokine receptors
complicate across-species comparison and studies on their
evolutionary origins (Beschin et al., 2001; Liongue and
Ward, 2007). As an exception, CRLF3 is phylogenetically
well-conserved and orthologs were detected in mammals, frog,
fish, non-vertebrate chordates and some, but not all insects
(this study; Wyder et al., 2007). CRLF3 has been classified
as a type I cytokine receptor of group 1 (‘‘prototypic type
I cytokine receptors’’) that also includes thrombopoietin
receptor, prolactin receptor, growth hormone receptor and
classical EpoR (Boulay et al., 2003). Cytokine receptors
of this group are single pass transmembrane receptors
that associate to mono- or heteromeric complexes and
transduce their activation into the cell through interaction
with JAKs.
We established adherent primary cell cultures from brains
of T. castaneum. Culture conditions supported the survival
of neurons and eliminated glial cells within 4 days in vitro.
Similar observations were previously made with primary
brain cell cultures form L. migratoria (Gocht et al., 2009).
Successful RNAi-mediated downregulation of protein expression
has previously been demonstrated in various developmental
stages of T. castaneum (Bucher et al., 2002; Ulrich et al.,
2015). In this study we extended the application of RNAi to
T. castaneum-derived neuronal cell cultures, by showing that
expression of particular proteins (such as rpt3 and Tc-CRLF3)
can be suppressed by soaking dsRNAi.
Epo promoted the survival of primary neuron cultures
from T. castaneum brains and effectively suppressed apoptotic
cell death induced by hypoxia and serum deprivation. This
confirmed the results from previous studies with primary
neuronal cultures from locust brains (Ostrowski et al.,
2011; Miljus et al., 2014) and suggested that Epo-mediated
neuroprotection might be a common mechanism in those
insects that contain orthologs of CRLF3 (e.g., T. castaneum,
L. migratoria, G. bimaculatus but not D. melanogaster).
RNAi-mediated knockdown of Tc-CRLF3 expression completely
abolished the neuroprotective effect of Epo, indicating that
this cytokine receptor is essential for initiating anti-apoptotic
mechanisms in T. castaneum brain neurons. In order to
minimize the risk that suppressed expression of another
protein besides Tc-CRLF3 interferes with Epo-mediated
neuroprotection, Tc-CRLF3 expression was knocked down
with two different dsRNA constructs that targeted different,
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FIGURE 5 | Downregulation of CRLF3 expression abolishes rhEpo-mediated neuroprotection of hypoxia-exposed neurons. (A) Schematic representation of
experimental procedure. (B) RNAi with dsRNA fragment 1 of the Tc-CRLF3 transcript. N = 16, 127,808 cells evaluated. (C) RNAi with dsRNA targeting fragment 2 of
the Tc-CRLF3 transcript. N = 14, 134,200 cells evaluated. Statistics: non-parametric Kruskal-Wallis test and Mann-Whitney U test for unmatched samples. P values
were corrected with the Benjamini-Hochberg procedure. ∗∗∗p < 0.001, ∗∗p < 0.01, ∗p < 0.05, n.s. not significant. Significance is shown with respect to the
treatment group marked by the arrowhead.
entirely non-overlapping sequences of the Tc-crlf3 gene
transcript. Both dsRNA constructs abolished Epo-mediated
protection of hypoxia-exposed beetle neurons. Complete loss
of Epo-mediated neuroprotection was previously achieved
by co-incubating hypoxia-exposed locust brain neurons with
JAK and STAT inhibitors (Miljus et al., 2014), suggesting that
Tc-CRLF3 is an upstream component of this neuroprotective
transduction pathway. This is in line with the presence of
predicted JAK docking sites in T. castaneum and human
CRLF3 (this study; Boulay et al., 2003) and the observation that
human CRLF3 activates STAT3 (Yang et al., 2009). However,
Tc-CRLF3-directed RNAi did not compromise neuronal survival
in normoxic and hypoxia-exposed neuronal cultures, suggesting
that it is not essential for cellular survival, though being
indispensable for Epo-mediated neuroprotection. Similarly,
studies on PC12 and HEK cells have not reported any obvious
decrease in viability following CRLF3 knockdown (Yang et al.,
2009; Hashimoto et al., 2012).
Epo-mediated neuroprotection shares a number of common
mechanisms between mammals (mostly studied in rodents) and
insects (studied in locusts and beetles). In both groups of animals
neuroprotection is mediated via JAK and STAT activation, while
mammalian neurons may additionally employ transduction
pathways involving MAPK, PI3K and NFκB (Digicaylioglu
and Lipton, 2001; Sirén et al., 2001; Miljus et al., 2014).
Various studies demonstrated optimum-type dose-response
curves for different concentrations of experimentally applied
Epo (this study; Sirén et al., 2001; Weishaupt et al., 2004;
Ostrowski et al., 2011; Miller et al., 2015) and Epo-induced
receptor endocytosis has been described for locust neurons
(Miljus et al., 2017) and mammalian erythroid progenitors
(Bulut et al., 2011). Importantly, the non-erythropoietic
splice variant EV-3 increased the survival of serum-deprived
primary cultured T. castaneum brain neurons (this study)
and protected both hypoxia-exposed locust brain neurons
(Miljus et al., 2017) and rat cortex neurons challenged with
glucose and oxygen deprivation (Bonnas, 2012; Bonnas
et al., 2017) from apoptotic cell death. This suggested a
greater similarity of the ligand binding regions of locust and
mammalian neuroprotective Epo receptors than between
mammalian neuroprotective and classical erythropoietic
EpoR.
CRLF3 has been implicated with typical cytokine-regulated
processes such as cell cycling and cellular morphogenesis
(Yang et al., 2009; Hashimoto et al., 2012) and alterations
of its expression have been detected in various types of
tumors (Dang et al., 2006; Yang et al., 2009) and patients
affected by ALS (Cirulli et al., 2015). However, the detailed
cellular function of CRLF3 has not been resolved and
descriptions of its functional domains and its subcellular
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localization are inconsistent. The present study deorphanizes
CRLF3 by identifying Epo-like signaling molecules as its
ligand. Preliminary own studies detected CRLF3 expression
in mouse brain, liver and kidney, suggesting that it mediates
functions in large parts of mammalian organisms. Whether
it functions as a neuroprotective or, more general, as a
cytoprotective Epo receptor in mammals including humans
needs to be studied by appropriate assays. Insects, such as
T. castaneum, but not Drosophila melanogaster that lack
both a CRLF3 ortholog and Epo-mediated neuroprotection,
may be used to search for additional tissue-protective
Epo receptors with conserved orthologs. Since insects lack
erythrocytes and ‘‘classical’’ EpoR, studies do not have to
consider interference of these mechanisms. Moreover, as
insects do not contain epo genes that can be identified by
sequence similarity, an ‘‘alternative’’ ligand awaits to be
identified that activates insect neuroprotective receptors such
as CRLF3 and may have mammalian orthologs with similar
functions.
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